Is Coagulation-related indicators associated with COVID19-related mortality? A evidence obtained from 663 Chinese patients with COVID-19 infection in a retrospective cohort study
Author:
Affiliation:
1. 925th Hospital of PLA Joint Logistics Support Force
2. GuiZhou University of Traditional Chinese Medicine
3. X&Y solutions Inc
4. Huazhong University of Science and Technology
5. Zhongnan Hospital of Wuhan University
Abstract
Background Several studies have found that coagulation-related markers are correlated with a poor prognosis in patients were diagnosed COVID-19 infection. However, the findings of these studies are constrained by methodology and data analysis. Furthermore, there would be little evidence to report trends in coagulation-related indicators over time all through the disease's progression. Methods From January 7, 2020 to February 28, 2020, we collected 663 participants in a Chinese hospital in a non-selective and consecutive manner. The association between baseline coagulation-related indicators and death was investigated using a standardized and two-piecewise Cox regression model. The GAMM (generalized additive mixed model) was used to examine the time-varying trend of indicators in non-survivors and survivors. Results Of the six coagulation-related indicators, basal-Log2D-dimer (D-D) was independently positively correlated with the risk of death .The area under the ROC (receiver operating characteristic curve) curve is 0.7937 and the optimum cut-off value is 0.4650mg/L. In the GAMM model, we found that thrombin time (TT ) (interaction coefficient 0.0071; 95%CI 0.0034to 0.0108) and activated partial thromboplastin time (aPTT) (interaction coefficient 0.0217; 95%CI 0.0160 to 0.0273) of non-survivors have been increasing progressively over time during the entire disease course compared with no fluctuations among survivors. An inverse U-shaped time-vary trend was observed in D-D, prothrombin time (PT) and international normalized ratio (INR) among non-survivors, while a steady trend was found among survivors. Conclusion Baseline D-D were independently positively correlated with the risk of death and have the potential to be used for risk assessment early on.
Publisher
Research Square Platform LLC
Reference39 articles.
1. China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019;Zhu N;N Engl J Med,2020
2. What we know so far: COVID-19 current clinical knowledge and research;Lake MA;Clin Med,2020
3. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review;Adhikari SP;Infect Dis Poverty,2020
4. Lum L, Tambyah P, Erratum. Outbreak of COVID-19 an urgent need for good science to silence our fears? Smedj 2020; 61: 169–169.
5. Clinical features and treatment of COVID-19 patients in northeast Chongqing;Wan S;J Med Virol,2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3